Literature DB >> 31625194

Two distinct variants of mycosis fungoides (MF): Folliculotropic MF and erythrodermic MF.

Hiroaki Kamijo1, Makoto Sugaya1,2.   

Abstract

Mycosis fungoides (MF) is the most frequent type of cutaneous T-cell lymphoma. Folliculotropic MF (fMF) and erythrodermic MF (eMF) are two distinct variants of MF. Both variants have been considered aggressive and most cases are less responsive to standard skin-directed therapies than classical MF. We, however, experienced many cases with fMF or eMF who showed indolent clinical courses. In this article, we reviewed 10 cases with fMF and 13 cases with eMF who came to our department between 2005 and 2017. In patients with fMF, monotherapy with topical corticosteroid was effective in two cases (20%) and ultraviolet phototherapy with oral retinoid controlled disease activity in two cases (20%). Five patients with eMF (38%) responded well to ultraviolet phototherapy. In conclusion, patients with early fMF and a subgroup of eMF patients have an indolent disease course, as was proposed among the specialists. Skin-directed therapies are preferable rather than aggressive treatment in those cases.
© 2019 Japanese Dermatological Association.

Entities:  

Keywords:  Sézary syndrome; erythrodermic MF; folliculotropic MF; mycosis fungoides; skin-directed therapies

Mesh:

Year:  2019        PMID: 31625194     DOI: 10.1111/1346-8138.15114

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  2 in total

1.  Folliculotropic Mycosis Fungoides in the Tumour Stage Mimics Venous Leg Ulcers.

Authors:  Torben Ramcke; Alexander Enk; Patrick Gholam
Journal:  Acta Derm Venereol       Date:  2021-09-03       Impact factor: 3.875

Review 2.  Folliculotropic Mycosis Fungoides: Current Guidance and Experience from Clinical Practice.

Authors:  Gabriele Roccuzzo; Luca Mastorino; Giuseppe Gallo; Paolo Fava; Simone Ribero; Pietro Quaglino
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-09-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.